Takeda Pharmaceutical Company Limited (TAK) Social Stream



Takeda Pharmaceutical Company Limited (TAK): $14.72

0.14 (+0.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About TAK

$CEMI Seems to me that the company would be a perfect takeover target considering the asset base in the diagnostic tests.

Especially with the depressed share price down from a recent high of $7.34 and having the dual test that differentiates between Covid and the flu pending approval.

Potential suitors are $JNJ, $AZN, $DGX, and $TAK.
The company has business relationships with all of them.

The mandates for Covid testing at all levels of government and in the schools and businesses will require more than one billion tests over the next year.

Chembio has the right test.

https://www.foxnews.com/health/cdc-labs-covid-tests-differentiate-flu.amp?__twitter_impression=true

Shorts need millions of shares. Buy a few shares today before the next p.r.
NevadaKid, published August 12, 2021

What Else are TAK Traders Talking About?


Other tickers frequently mentioned alongside TAK are CEMI, JNJ, AZN and DGX.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4641 seconds.